Clinical Leader - Helping clinical research professionals connect and collaborate

The Real Cost Of Sites Working Without An Enforceable Agreement: Why Your Site's Quality Of Earnings Is Suspect

Starting site work before an enforceable agreement may look like flexibility, but it can drain leverage, create unrecoverable costs, and raise financial reporting and GCP concerns.

GUEST COLUMNISTS

Coalition Takes Guesswork Out Of Charcot-Marie-Tooth Disease Research With New Guidance
A new Charcot-Marie-Tooth guidance introduces practical recommendations to help sponsors design clearer, more patient-centered, regulator-ready trials.
How AI Will Reshape Study Start-Up
AI can help study start-up teams move from tracking delays to predicting risks—if human judgment, data quality, and governance stay central.
Clinical Supply Systems Need IT General Controls
Validating a clinical trial system does not prove it stays trustworthy. IT general controls can protect data, supply decisions and patient safety long after go-live.
Medical Affairs: The Missing Link To Oncology Drug Adoption
Learn how medical affairs can help oncology teams turn strong clinical evidence into real-world adoption by connecting development strategy with clinical practice.
How Can We Influence Others For Better Outcomes In Clinical Research?
Learn how to use the Delphi method to build consensus and drive better decisions in clinical research — even when stakeholders start far apart.
What Will Life Science Orgs Do When The AI Bill Comes Through?
AI is transforming clinical development, but what happens when usage costs spike? Jon Newton explains how to govern it before the bill lands.
Clinical Trial Standards — What They Are And Why They're Indispensable
Clinical trial standards are essential. But to interpret changes, preserve meaning, and assess downstream impact, context is key.
Last-Mile Lessons For Depot-To-Site Delivery
Depot-to-site delivery is more than a courier handoff. See how reconciliation gaps, temperature risks, and mismatched SLAs can turn last-mile issues into trial delays.

CLINICAL TRIAL WHITE PAPERS

Rescue Treatment Design In Wet AMD And Retinal Vascular Trials
How trials protect vision without muddying the data: explore the five design choices behind an effective rescue treatment strategy.

UK Clinical Trial Regulations Reform
7/24/2026

UK trial regulations have been overhauled. Learn what faster approval pathways, stricter publication rules, and longer retention requirements mean for your operations.
How Sponsors Are Responding To FDA's RTCT Request For Information
9/9/2026

Let's take a look at where continuous, real-time regulatory review can meaningfully speed drug development, and where it likely won't help much.
Connected Trial Execution: Why Integrating IRT, eCOA And Clinical Supply Matters More Than Ever
9/16/2026

Many sponsors are still managing IRT, eCOA, and Clinical Supply for complex trials as separate functions, creating unnecessary risk. Explore what is needed to integrate these workflows safely.
Digital Twins: From Protocol Design to Predictive Study Execution
9/14/2026

A growing generation of AI-enabled digital twin approaches offers a new path. Instead of treating the protocol as a static document, organizations can model it as a dynamic system.
Challenges, Opportunities For Recruitment In The Digital Age
10/20/2025

Health literacy gaps and online misinformation hinder clinical trial recruitment. Meeting patients where they are — digitally and educationally — can improve engagement and enrollment success.

More Clinical Trial White Papers

CLINICAL TRIAL APP NOTES & CASE STUDIES

DECODE CRS: Accelerating Immunotherapy Access And De-risking CRS
6/18/2026

How does the DECODE CRS Coalition help trial sponsors standardize protocols and build a first-of-its-kind wearable dataset to lower development costs and safely de-risk outpatient care?
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study
1/6/2025

Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
Executing Concurrent Decentralized RCTs And RWE At Scale
3/31/2026

See how a team of four managed data for 40 peer-reviewed studies and 200,000 participants.
Guiding GLP-1 Participants Through The Challenge Of Retention
12/4/2025

Learn how remote lifestyle coaching can combat high dropout rates in metabolic research by offering the support participants need to maintain adherence and ensure data integrity.
Successful SwissMedic Marketing Authorization Application For An Oncology Therapy
6/4/2026

See how strategic EU dossier adaptation and Swiss-specific regulatory expertise enabled a successful SwissMedic submission and accelerated market access for an oncology therapy.
Case Management Accelerates Shipment For SCN1A+ Dravet Syndrome Gene Therapy
3/12/2026

Consider this streamlined, end-to-end solution that helped safeguard study timelines and ensured that patients with urgent medical needs could receive treatment without delay.

More Clinical Trial App Notes & Case Studies

NEWSLETTER ARCHIVE

More Newsletters

RECRUITMENT AND DIVERSITY

This section includes some helpful resources regarding patient recruitment and diversity in clinical trials, including this link to the FDA's guidance on diversity action plans.

Turn AI Visibility Into Action: Build Explanation Layers For Different Stakeholders

AI visibility isn’t just about being found. Ross Jackson coaches sponsors on how to influence AI to provide clear stakeholder pathways for clinical trial involvement.
Your Trial Shows Up In AI. Now What?

AI can explain your trial — but can it help patients act? Ross Jackson shares how sponsors can turn visibility into trust and next steps.
Sustainable Patient Engagement: Your Enrollment And Representation Depend On It

Early and ongoing patient engagement is a crucial component to staving off recruitment trouble and securing proper patient representation. Boehringer Ingelheim's Karen Correa, Ph.D., explains how.

FOCUS ON PATIENTS

Why Oncology Programs Can't Rely On An Inside View Alone

Discover how looking outside a program can help oncology teams test assumptions, improve feasibility, and make stronger development decisions.
The Promise Of MRD-Guided CAR-T Treatment

Minimal residual disease markers can reveal relapse before clinical signs appear, when off-the-shelf cell therapy may have its greatest advantage.
The Pharmacy Benefit No One Is Managing: Clinical Research As A Care Option

Pharmacies could make trials more accessible — if they preserve patient trust while research partners handle the operational burden.